TechDialybrid raises €15 million to test a silk-based graft
Tech Funding News reports that XGEN Venture led the Series A, with participation from CDP Venture Capital SGR’s Rilancio Fund.
TLDR
Dialybrid has raised €15 million to test a graft woven from silk, Tech Funding News reports. New investor XGEN Venture led the Series A, joined by CDP Venture Capital SGR’s Rilancio Fund. XGEN is an Italian life sciences fund that closed at €180 million in December 2024.
Dialybrid raises €15 million to test a silk-based graft
Tech Funding News reports that XGEN Venture led the Series A, with participation from CDP Venture Capital SGR’s Rilancio Fund.
TLDR
Dialybrid has raised €15 million to test a graft woven from silk, Tech Funding News reports. New investor XGEN Venture led the Series A, joined by CDP Venture Capital SGR’s Rilancio Fund. XGEN is an Italian life sciences fund that closed at €180 million in December 2024.
